Northeast ALS Consortium
Overview
Northeast ALS Consortium is a non-profit international consortium of clinical research sites that collaboratively conducts research to accelerate the development of new treatments for Amyotrophic Lateral Sclerosis (ALS) and motor neuron disease (MND).
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Revalesio | Sep 2017 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Northeast ALS Consortium based?
Northeast ALS Consortium is headquartered in Boston, Massachusetts, United States.
When was Northeast ALS Consortium founded?
Northeast ALS Consortium was founded in 1995.
How many portfolio companies does Northeast ALS Consortium have?
Northeast ALS Consortium has 1 portfolio company in Caplight's dataset.
What are some companies in Northeast ALS Consortium's portfolio?
Portfolio companies visible on Caplight include Revalesio.
What was Northeast ALS Consortium's most recent investment shown here?
Northeast ALS Consortium's most recent investment in this portfolio sample was in Revalesio in 2017.
What sectors does Northeast ALS Consortium focus on?
Northeast ALS Consortium focuses on Healthcare & Life Sciences.
What company stages does Northeast ALS Consortium focus on?
Stage focus information for Northeast ALS Consortium is not publicly available.